SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Immucor -- Ignore unavailable to you. Want to Upgrade?


To: technetx who wrote (165)8/26/1998 10:39:00 AM
From: Mason Barge  Read Replies (2) | Respond to of 422
 
I'm sure you probably have seen this. Although we are sometimes a little critical of the co's low visibility, let's be (very) thankful for what we have, that is, management that is focused on value. While other companies might do things differently, Immucor mgt has always followed a consistent, energetic, and reasonable program to grow revenues and company value:

NORCROSS, Ga., Aug. 26 /PRNewswire/ -- Immucor, Inc. (Nasdaq: BLUD) announced today that its Board of Directors has authorized the Company to repurchase up to an additional 800,000 shares of its common stock. The Company instituted a repurchase program in June of 1997 for up to 810,000 shares. To date 582,000 shares have been purchased under the 1997 program.

"We believe market conditions have provided us with an excellent opportunity to enhance shareholder value by purchasing stock at very attractive prices. The combined programs give us the opportunity to repurchase an additional one million shares," said Edward L. Gallup, President of Immucor. Mr. Gallup also noted that the Company is not committed to purchase any minimum number of shares, and the Company may terminate the repurchase program at any time.

Commenting further, Mr. Gallup stated, "We are very pleased with our initial success with the ROSYS Plato and the ABS2000 (FDA cleared July 6, 1998). We expect installations to begin in early September and believe the associated revenue and earnings growth will ensure that our share repurchase efforts will add significant value for our shareholders.



To: technetx who wrote (165)8/27/1998 6:29:00 AM
From: Thomas Kirwin  Respond to of 422
 
AABB Annual Convention

Technetx,

Immucor is scheduled to participate in the AABB Annual Convention as highlighted on their website immucor.com, "Come see The Immucor "Fab 4": AABB Booth 1011, November 1-4, 1998".

The 51st Annual Meeting of the American Association of Blood Banks will take place October 31 - November 4, 1998 in Philadelphia, Pennsylvania. The preliminary program will be mailed to the membership in May, 1998.

aabb.org

Regards,

Tom



To: technetx who wrote (165)8/31/1998 9:28:00 PM
From: Thomas Kirwin  Respond to of 422
 
Walberg: Does size matter? Small caps vs large caps

Interesting.....

quicken.com

Regards,

Tom

P.S. Just thought that I'd provide some reading material as we wait for the sales announcements and earnings.



To: technetx who wrote (165)9/5/1998 8:27:00 AM
From: Thomas Kirwin  Respond to of 422
 
Immucor Up 8% - Week Ending Friday, September 04, 1998

08/28 09/04 52 WK 52 WK P/E WEEK
SECURITY CLOSE CLOSE HIGH LOW RATIO CHNG
-------------------------------------------------------------------

Immucor.............8 1/2 9 3/16 12 7 1/16 38 +8.0%

Immucor gained in a down market!

Regards,

Tom



To: technetx who wrote (165)9/5/1998 3:30:00 PM
From: Thomas Kirwin  Read Replies (1) | Respond to of 422
 
Heavy Buying Just Before Closing Bell

Hello,

The BLUD ticker tape reveals that there were a flurry of buys just
before the market close on September 4th.

Time Tran Price Size

15:59:05 Buy 9 3/16 500
15:58:48 Buy 9 3/16 100
15:55:33 Buy 9 1/8 1200
15:55:22 Buy 9 1/8 2300
15:55:05 Buy 9 1/8 1000
15:54:49 Buy 9 1/8 1000
15:50:03 Buy 9 1/8 2000
15:43:13 ?Sell? 9 1200

quote.com

Lets see if the buying continues. If so, Immucor may gap up at the
open on Tuesday, September 8th.

Regards,

Tom